• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5071016)   Today's Articles (71)
For: Maani Z, Farajnia S, Rahbarnia L, Hosseingholi EZ, Khajehnasiri N, Mansouri P. Rational design of an anti-cancer peptide inhibiting CD147 / Cyp A interaction. J Mol Struct 2023;1272:134160. [PMID: 36128074 PMCID: PMC9479519 DOI: 10.1016/j.molstruc.2022.134160] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2022] [Revised: 08/27/2022] [Accepted: 09/13/2022] [Indexed: 11/25/2022]
Number Cited by Other Article(s)
1
Qin Q, Feng M, Zhang K, Mo Z, Liu Y, Ma Y, Liu X. Basigin in cerebrovascular diseases: Roles, mechanisms, and therapeutic target potential. Eur J Pharmacol 2025;989:177232. [PMID: 39734038 DOI: 10.1016/j.ejphar.2024.177232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2024] [Revised: 11/24/2024] [Accepted: 12/23/2024] [Indexed: 12/31/2024]
2
Rai N, Tiwari RT, Sahu A, Verma E, Rathore S, Patil S, Patil AG. Exploring Tryptophan-based Short Peptides: Promising Candidate for Anticancer and Antimicrobial Therapies. Anticancer Agents Med Chem 2025;25:124-133. [PMID: 39297455 DOI: 10.2174/0118715206260662240613054521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2024] [Revised: 05/02/2024] [Accepted: 05/10/2024] [Indexed: 02/18/2025]
3
Maani Z, Rahbarnia L, Bahadori A, Chollou KM, Farajnia S. Spotlight on HIV-derived TAT peptide as a molecular shuttle in drug delivery. Drug Discov Today 2024;29:104191. [PMID: 39322176 DOI: 10.1016/j.drudis.2024.104191] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2024] [Revised: 09/08/2024] [Accepted: 09/19/2024] [Indexed: 09/27/2024]
4
Cui Z, Zhou Z, Sun Z, Duan J, Liu R, Qi C, Yan C. Melittin and phospholipase A2: Promising anti-cancer candidates from bee venom. Biomed Pharmacother 2024;179:117385. [PMID: 39241571 DOI: 10.1016/j.biopha.2024.117385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2024] [Revised: 08/20/2024] [Accepted: 08/30/2024] [Indexed: 09/09/2024]  Open
5
He H, He B, Guan L, Zhao Y, Jiang F, Chen G, Zhu Q, Chen CYC, Li T, Yao J. De novo generation of SARS-CoV-2 antibody CDRH3 with a pre-trained generative large language model. Nat Commun 2024;15:6867. [PMID: 39127753 PMCID: PMC11316817 DOI: 10.1038/s41467-024-50903-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2023] [Accepted: 07/23/2024] [Indexed: 08/12/2024]  Open
6
Sinha B, Choudhury Y. Revisiting edible insects as sources of therapeutics and drug delivery systems for cancer therapy. Front Pharmacol 2024;15:1345281. [PMID: 38370484 PMCID: PMC10869617 DOI: 10.3389/fphar.2024.1345281] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2023] [Accepted: 01/22/2024] [Indexed: 02/20/2024]  Open
7
Bakhtiyari N, Farajnia S, Ghasemali S, Farajnia S, Pormohammad A, Saeidvafa S. Strategies to Overcome Antimicrobial Resistance in Nosocomial Infections, A Review and Update. Infect Disord Drug Targets 2024;24:e260124226226. [PMID: 38284691 DOI: 10.2174/0118715265276529231214105423] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2023] [Revised: 11/12/2023] [Accepted: 11/17/2023] [Indexed: 01/30/2024]
8
Yu X, Jia S, Yu S, Chen Y, Zhang C, Chen H, Dai Y. Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies. J Nanobiotechnology 2023;21:454. [PMID: 38017537 PMCID: PMC10685715 DOI: 10.1186/s12951-023-02223-4] [Citation(s) in RCA: 16] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2023] [Accepted: 11/19/2023] [Indexed: 11/30/2023]  Open
9
Nabizadeh S, Rahbarnia L, Nowrozi J, Farajnia S, Hosseini F. Rational design of hybrid peptide with high antimicrobial property derived from Melittin and Lasioglossin. J Biomol Struct Dyn 2023;42:13091-13099. [PMID: 37885265 DOI: 10.1080/07391102.2023.2274971] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2023] [Accepted: 10/18/2023] [Indexed: 10/28/2023]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA